Replimune Strengthens Executive Team with the Appointment of Jean Franchi as Chief Financial Officer

NEXT STORY
BeyondSpring’s Abstracts on Clinical Evidence for Bone Marrow Stem Cell Protection as Plinabulin’s Mechanism of Action for CIN Accepted at American Society of Hematology’s 2019 Annual Meeting
PREV STORY
Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Wesana Health Commences Trading on the CSE

author_avatar
NASDAQ Market News

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline – CRMD

author_avatar
NASDAQ Market News

1910 Genetics Debuts with $26M to Accelerate the Design of Small Molecule and Protein Therapeutics Through AI, Computation and Biological Automation

author_avatar
NASDAQ Market News